
Today, we launched Only Possible Here, The Campaign to End Cancer, celebrating the innovations and advancements that are only possible here at MD Anderson. Read more: spr.ly/60167nfhw #EndCancer
Peter WT Pisters, MD
4.8K posts

@ppisters
President of The University of Texas MD Anderson Cancer Center, @UTMDAnderson. Cancer surgeon, researcher, health care leader. Views are my own. #EndCancer

Today, we launched Only Possible Here, The Campaign to End Cancer, celebrating the innovations and advancements that are only possible here at MD Anderson. Read more: spr.ly/60167nfhw #EndCancer


















UT MD Anderson has joined a consortium dedicated to accelerating the elimination of cervical cancer worldwide. This collaboration with the Elimination Partnership in Cervical Cancer expands our global oncology efforts, further advancing our commitment to #EndCancer. @kmschmeler spr.ly/6019B8NEkU

Congratulations to UT MD Anderson president @ppisters on being named by @modrnhealthcr as one of the most influential healthcare executives for 2026. More about the honor and Dr. Pisters' leadership: spr.ly/6015B8IqCS #EndCancer












Two researchers will be honored with @ASCO’s 2026 Special Awards: Sharon Giordano for the Gianni Bonadonna Breast Cancer Award and Eduardo Vilar-Sanchez for the ASCO-American Cancer Society Cancer Prevention Award. spr.ly/6010B8X8u0 @shgiordano @evilarsan #ASCO26 #EndCancer








Congratulations to Albert Koong, M.D., Ph.D., on being named chief scientific officer at UT MD Anderson, effective June 1. An internationally recognized physician-scientist and leader, Koong will help advance innovation and lead our laboratory and clinical research enterprise as we work to #EndCancer. Read more: spr.ly/6013B8DN0h @ACKoongMDPhD

We are grateful to @CPRITTexas for their continued support of our mission to #EndCancer. This gift will support young cancer survivors, research efforts, and faculty recruitment and training programs: spr.ly/6017B860qU

The @us_fda has issued a 'safe to proceed' to a clinical trial for a new application for a novel CAR T cell therapy for some lymphoma patients. Dr. Sattva Neelapu shares more. spr.ly/6015BBLBuD